Angel Petropanagos and Andria Bianchi highlight the lack of agreement about what “advocacy” means in healthcare and suggest that a narrowly defined advocacy role is necessary for the work of practicing healthcare ethicists.
Dessislava Fessenko shows that while artificial intelligence might revolutionize drug development, its use comes with risks and potential ethical implications. Iterative ethics oversight from the get-go is needed to address the looming concerns.
Daryl Pullman examines a recent article that defends expanded eligibility for medical assistance in dying on questionable grounds of autonomy and harm reduction.
Eric Mathison summarizes the final report of the federal Special Joint Committee on Medical Assistance in Dying (MAiD) as it relates to disability.
Matthew Herder presents his opening statement to the House of Commons’ Standing Committee on Health on May 2, 2023. In February, Herder resigned from the Patented Medicine Prices Review Board (PMPRB).
Impact Ethics 